LncRNAs in Cardiovascular Development & Disease

Long noncoding rnas (lncrnas) are emerging as powerful regulators of cardiac development and disease. Here is the latest research.

April 28, 2020
Open Access

Noncoding RNAs as Biomarkers for Acute Coronary Syndrome

BioMed Research International
Lijie Wang, Yuanzhe Jin
May 12, 2020

Long non-coding RNAs in hepatocellular carcinoma: Ordering of the complicated lncRNA regulatory network and novel strategies for HCC clinical diagnosis and treatment

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Changyao LiLei Zhang
August 9, 2020

Endogenous Retrovirus-Derived lncRNA BANCR Promotes Cardiomyocyte Migration in Humans and Non-human Primates

Developmental Cell
Kitchener D WilsonJoseph C Wu
May 16, 2020
Open Access

Construction of a ceRNA coregulatory network and screening of hub biomarkers for salt-sensitive hypertension

Journal of Cellular and Molecular Medicine
Ling ZhangYu-Tao Xiang
May 7, 2020
Open Access

H19/TET1 axis promotes TGF-β signaling linked to endothelial-to-mesenchymal transition

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Tiefeng CaoYingqun Huang
April 15, 2020

Non-coding RNAs in Physiological Cardiac Hypertrophy

Advances in Experimental Medicine and Biology
Lijun WangJunjie Xiao
August 11, 2020

The Long Non-coding Road to Atherosclerosis

Current Atherosclerosis Reports
Tatjana Josefs, Reinier A Boon
July 24, 2020
Open Access

Long Noncoding RNAs in Atherosclerosis and Vascular Injury: Pathobiology, Biomarkers, and Targets for Therapy

Arteriosclerosis, Thrombosis, and Vascular Biology
Jacob B Pierce, Mark W Feinberg
July 10, 2020
Open Access

A Long Noncoding RNA CHAIR protects the heart from pathological stress

Clinical Science
Yanxia QianJunhong Wang
March 21, 2020

Long noncoding RNA ILF3-AS1 regulates myocardial infarction via the miR-212-3p/SIRT1 axis and PI3K/Akt signaling pathway

European Review for Medical and Pharmacological Sciences
J-Y ZhangJ Sun
April 15, 2020

Comprehensive Overview of Non-coding RNAs in Cardiac Development

Advances in Experimental Medicine and Biology
Enrico PozzoMaurilio Sampaolesi
March 25, 2020

Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular disease

Current Opinion in Cardiology
Sadhan DasRama Natarajan

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2020 Meta ULC. All rights reserved